HRT Financial’s Health Catalyst HCAT Stock Holding History

HRT Financial’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$308K	Buy	243,191 +230,553	+1,824%	+$434K	﹤0.01%	2855
2025 Q4	$30K	Buy	12,638 +968	+8%	+$2.65K	﹤0.01%	2942
2025 Q3	$33K	Buy	+11,670	New	+$39.9K	﹤0.01%	2647
2025 Q2	–	Sell	-13,865	Closed	-$62K	–	2996
2025 Q1	$62K	Buy	+13,865	New	+$73.4K	﹤0.01%	2217
2024 Q4	–	Sell	-10,026	Closed	-$81K	–	2718
2024 Q3	$81K	Buy	+10,026	New	+$72.4K	﹤0.01%	2066
2024 Q2	–	Sell	-111,842	Closed	-$842K	–	2553
2024 Q1	$842K	Sell	111,842 -79,241	-41%	-$723K	0.01%	967
2023 Q4	$1.77M	Buy	+191,083	New	+$1.56M	0.01%	708
2022 Q2	–	Sell	-25,968	Closed	-$678K	–	3233
2022 Q1	$678K	Buy	+25,968	New	+$737K	﹤0.01%	1412

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's HCAT Position: Q1 2026 in Review

HRT Financial increased its Health Catalyst (HCAT) stake by 1,824% in Q1 2026, buying an estimated $434K and bringing the position to 243,191 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

HRT Financial first reported a position in HCAT in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.77M in Q4 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

HRT Financial held 243,191 shares of Health Catalyst worth $308K as of Q1 2026.
HRT Financial bought 230,553 Health Catalyst shares in Q1 2026, an estimated $434K.
Health Catalyst made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2855 holding.
HRT Financial first reported a position in Health Catalyst in Q1 2022 and has held it in 8 quarters since.
HRT Financial's Health Catalyst position peaked at $1.77M in Q4 2023.
130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.